Skip to main content
. Author manuscript; available in PMC: 2015 Jul 1.
Published in final edited form as: Nanomedicine. 2014 Mar 17;10(5):897–900. doi: 10.1016/j.nano.2014.03.006

Figure 4.

Figure 4

Xenograft tumor growth of A549 cells pre-treated with NP(siPHB1) vs. Lipo2K(siPHB1), saline, and control NP (n=4–5). *P<0.05, NP vs. Lipo2K.